Cargando…

Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is a relatively rare and highly lethal tumor with few treatment options. Thus, it is important to identify prognostic markers that can help clinicians diagnose mesothelioma earlier and assess disease activity more accurately. Alternative splicing (AS) events h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Jinzhi, Yang, Hainan, Xu, Tianwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299698/ https://www.ncbi.nlm.nih.gov/pubmed/34294080 http://dx.doi.org/10.1186/s12885-021-08548-3

Ejemplares similares

Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer
por: Liu, Qingyang, et al.
Publicado: (2022)

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022)

Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration
por: Zhang, Dongni, et al.
Publicado: (2022)

Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
por: Xu, Xiaoling, et al.
Publicado: (2020)

Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification
por: Su, Hong-xin, et al.
Publicado: (2022)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma
por: Huang, Tianpeng, et al.
Publicado: (2021)

Identification and Characterisation of Infiltrating Immune Cells in Malignant Pleural Mesothelioma Using Spatial Transcriptomics
por: Shek, Dmitrii, et al.
Publicado: (2023)

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
por: Shi, Jian-yu, et al.
Publicado: (2021)

Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009)

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients
por: Dai, Zhibing, et al.
Publicado: (2023)

High systemic immune–inflammation index represents an unfavorable prognosis of malignant pleural mesothelioma
por: Ma, Ming, et al.
Publicado: (2019)

Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma
por: Xue, Dan, et al.
Publicado: (2020)

Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer
por: Wu, Tianqi, et al.
Publicado: (2021)

Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I–III lung squamous cell carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Identification and Characterization of Immunogene-Related Alternative Splicing Patterns and Tumor Microenvironment Infiltration Patterns in Breast Cancer
por: Guo, Shuang, et al.
Publicado: (2022)

Alternative Splicing in Myeloid Malignancies
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer
por: Wang, Lin, et al.
Publicado: (2020)

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma
por: Napolitano, Andrea
Publicado: (2019)

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
por: Napoli, Francesca, et al.
Publicado: (2021)

A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma
por: Ma, Shouzheng, et al.
Publicado: (2022)

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
por: Sciarrillo, Rocco, et al.
Publicado: (2018)

Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors
por: Liu, Qi-Fang, et al.
Publicado: (2021)

A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival
por: Shao, Ming‐Ming, et al.
Publicado: (2022)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

CUL4B is a Potential Novel Prognostic Biomarker and is Correlated with Immune Infiltrates in Malignant Pleural Mesothelioma
por: Liu, Lu, et al.
Publicado: (2022)

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer
por: Wang, Shizhi, et al.
Publicado: (2022)

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2022)

Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

Alternative Splicing in Plant Immunity
por: Yang, Shengming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nvqhh3kfstmcv6hrbfub0teltt